| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.1 |